1 – 10 of 240
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Clinical Implications of Discrepancy between One-stage Clotting and Chromogenic Factor IX Activity in Haemophilia B
(
- Contribution to journal › Article
-
Mark
International Prophylaxis Study Group (IPSG) haemophilia joint MRI scale version 2.0
(
- Contribution to journal › Letter
-
Mark
Origin of pathogenic variant and mosaicism in families with a sporadic case of haemophilia B
2024) In Haemophilia(
- Contribution to journal › Article
-
Mark
Prophylactic Treatment of Children with Hemophilia in Sweden
(
- Contribution to journal › Scientific review
-
Mark
Recombinant factor IX Fc for the treatment of hemophilia B
(
- Contribution to journal › Scientific review
- 2023
-
Mark
Factor VIII genotype and the risk of developing high-responding or low-responding inhibitors in severe hemophilia A : data from the PedNet Hemophilia Cohort of 1,202 children
(
- Contribution to journal › Article
-
Mark
Primary prophylaxis in children with severe haemophilia A and B-Implementation over the last 20 years as illustrated in real-world data in the PedNet cohorts
(
- Contribution to journal › Article
-
Mark
Haemophilia A and B - evaluation of the Swedish prophylactic regimen by magnetic resonance imaging
(
- Contribution to journal › Article
-
Mark
BAY 81-8973 Efficacy and Safety in Previously Untreated and Minimally Treated Children with Severe Hemophilia A : The LEOPOLD Kids Trial
(
- Contribution to journal › Article
- 2022
-
Mark
Silent variant in F8:c.222G>T (p.Thr74Thr) causes a partial exon skipping in a patient with mild hemophilia A
(
- Contribution to journal › Article